Patents by Inventor Kuo-Kuei Huang

Kuo-Kuei Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition with immunomodulating function
    Patent number: 8597693
    Abstract: A pharmaceutical composition with an immunomodulating function is provided, including an extract of Bupleurum obtained by grinding the Bupleurum, adding the ground Bupleurum to a solvent and isolating the extract from the solvent, wherein the Bupleurum comprises Bupleurum krlovianum, Bupleurum longiradiatum, Bupleurum smithii, Bupleurum pusillum, Bupleurum longicaule, Bupleurum salicifolium, Bupleurum scorzonerifolium and Bupleurums with at least one of the nucleotide sequences selected from a group consisting of SEQ ID NOs. 1˜6 and a nucleotide sequence with no more than 1% of the nucleotide sequence divergences of SEQ ID NOs. 1˜6, or combinations thereof.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: December 3, 2013
    Assignee: Industrial Technology Research Institute
    Inventors: Ying-Chu Shih, Lain-Tze Lee, Bie-Shung Tsai, Jir-Mehng Lo, Tien-Soung Tong, Jenn-Line Sheu, Kuo-Kuei Huang, Ying-Fei Tsai, Yi-Ching Lee, Hui-Ju Liang, Jui-Hung Yen, Cheng-Yu Lee
  • PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATING FUNCTION
    Publication number: 20120003250
    Abstract: A pharmaceutical composition with an immunomodulating function is provided, including an extract of Bupleurum obtained by grinding the Bupleurum, adding the ground Bupleurum to a solvent and isolating the extract from the solvent, wherein the Bupleurum comprises Bupleurum krlovianum, Bupleurum longiradiatum, Bupleurum smithii, Bupleurum pusillum, Bupleurum longicaule, Bupleurum salicifolium, Bupleurum scorzonerifolium and Bupleurums with at least one of the nucleotide sequences selected from a group consisting of SEQ ID NOs. 1˜6 and a nucleotide sequence with no more than 1% of the nucleotide sequence divergences of SEQ ID NOs. 1˜6, or combinations thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: January 5, 2012
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Ying-Chu Shih, Lain-Tze Lee, Bie-Shung Tsai, Jir-Mehng Lo, Tien-Soung Tong, Jenn-Line Sheu, Kuo-Kuei Huang, Ying-Fei Tsai, Yi-Ching Lee, Hui-Ju Liang, Jui-Hung Yen, Cheng-Yu Lee
  • PLANT DERIVED COMPOUNDS AND COMPOUND FORMULAE CONTAINING THE SAME FOR THE TREATMENT OF CERVICAL CANCER
    Publication number: 20090137661
    Abstract: A composition for reducing the activity of a cervical cancer cell is provided. The composition includes at least one of the following compounds: isopsoralen, triptolide, baicalein, gallic acid, quercetin, gossypol-acetic acid, baicalin, berberine hydrochloride, and derivatives thereof in a sufficient amount to reduce the activity of the cervical cancer cell in the subject.
    Type: Application
    Filed: November 25, 2008
    Publication date: May 28, 2009
    Inventors: Ming-Kuang Shih, Yu-Chou Chao, Ying-Chu Shih, Kuo-Kuei Huang
  • Human tissue urokinase type plasminogen activator formulation
    Publication number: 20030077682
    Abstract: This invention relates to an anhydrous arginine-free formulation including human tissue urokinase type plasminogen activator, lysine, phosphoric acid, and a non-ionic detergent, wherein the human tissue urokinase type plasminogen activator, lysine, phosphoric acid, and non-ionic detergent are in quantities of 10-60 mg, 100-700 mg, 20-100 mg, and 0.2-5 mg, respectively; or in quantities of the same relative ratio.
    Type: Application
    Filed: September 5, 2002
    Publication date: April 24, 2003
    Inventors: Paul Porwen Hung, Kenneth S. S. Chang, Bryan T. H. Wu, Kuo-Kuei Huang